<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kawase A</submitter><funding>Japan Society for the Promotion of Science</funding><pagination>8573</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9369313</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(15)</volume><pubmed_abstract>SLC25A39/40, involved in mitochondrial GSH (mGSH) import from the cytoplasm, is essential for protection against oxidative stress and mitochondrial dysfunction. We examined the effects of cholestasis, through bile duct ligation (BDL) and lipopolysaccharide (LPS)-induced inflammation in mice, on Slc25a39/40 expression. Additionally, we used human clear cell renal carcinoma (KMRC-1) cells to elucidate the mechanism of regulation of SLC25A39/40 expression in the kidneys after LPS treatment. BDL resulted in a decrease in &lt;i>Slc25a39&lt;/i> mRNA in the liver and a decrease in &lt;i>Slc25a39/40&lt;/i> mRNA and protein in the kidneys. Consequently, there was a significant decrease in mGSH levels in the kidneys of BDL mice compared with those in sham mice. LPS treatment resulted in increased &lt;i>Slc25a40&lt;/i</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Slc25a39 and Slc25a40 Expression in Mice with Bile Duct Ligation or Lipopolysaccharide Treatment.</pubmed_title><pmcid>PMC9369313</pmcid><funding_grant_id>21K06698</funding_grant_id><pubmed_authors>Kawase A</pubmed_authors><pubmed_authors>Shimada H</pubmed_authors><pubmed_authors>Hatanaka M</pubmed_authors><pubmed_authors>Matsuda N</pubmed_authors><pubmed_authors>Iwaki M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Slc25a39 and Slc25a40 Expression in Mice with Bile Duct Ligation or Lipopolysaccharide Treatment.</name><description>SLC25A39/40, involved in mitochondrial GSH (mGSH) import from the cytoplasm, is essential for protection against oxidative stress and mitochondrial dysfunction. We examined the effects of cholestasis, through bile duct ligation (BDL) and lipopolysaccharide (LPS)-induced inflammation in mice, on Slc25a39/40 expression. Additionally, we used human clear cell renal carcinoma (KMRC-1) cells to elucidate the mechanism of regulation of SLC25A39/40 expression in the kidneys after LPS treatment. BDL resulted in a decrease in &lt;i>Slc25a39&lt;/i> mRNA in the liver and a decrease in &lt;i>Slc25a39/40&lt;/i> mRNA and protein in the kidneys. Consequently, there was a significant decrease in mGSH levels in the kidneys of BDL mice compared with those in sham mice. LPS treatment resulted in increased &lt;i>Slc25a40&lt;/i</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T23:46:47.636Z</modification><creation>2025-02-19T03:32:08.676Z</creation></dates><accession>S-EPMC9369313</accession><cross_references><pubmed>35955707</pubmed><doi>10.3390/ijms23158573</doi></cross_references></HashMap>